A rare case of methemoglobinemia in a preterm newborn with unclear etiology

J Neonatal Perinatal Med. 2024;17(2):261-264. doi: 10.3233/NPM-230163.

Abstract

Cyanosis is a bluish discoloration of the tissues due to increased levels of deoxygenated hemoglobin in capillaries. It is a common finding in newborn infants that can be caused by different diseases, including pulmonary, cardiac, infectious, and hematological disorders. Methemoglobinemia is a rare cause of cyanosis, in which hemoglobin is oxidized, changing its heme iron configuration from the ferrous (Fe2 +) to the ferric (Fe3 +) state, creating methemoglobin (Met-Hb), a form that does not bind oxygen, leading to decreased oxygen delivery to the tissues and cyanosis. We report a rare case of a preterm newborn, who developed cyanosis and worsening hypoxemia on day ten of life, she was found to have elevated Met-Hb percentage in blood gas analysis that required treatment with intravenous methylene blue. Her symptoms resolved after a period of maintenance treatment with oral methylene blue and ascorbic acid, and the etiology of her disease remains unclear.

Keywords: Congenital; cyanosis; methemoglobinemia; methylene blue; preterm.

Publication types

  • Case Reports

MeSH terms

  • Ascorbic Acid* / administration & dosage
  • Ascorbic Acid* / therapeutic use
  • Blood Gas Analysis
  • Cyanosis* / etiology
  • Female
  • Humans
  • Hypoxia / etiology
  • Infant, Newborn
  • Infant, Premature*
  • Methemoglobinemia* / diagnosis
  • Methemoglobinemia* / etiology
  • Methylene Blue* / therapeutic use